Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on November 16, 2012. The report details a material definitive agreement entered into on the same date regarding the company's accounts receivables securitization facility.
Key Financial Metrics
- Facility Size: $700 million base limit.
- Expansion Option: Additional $250 million available for seasonal needs during December and March quarters, subject to bank approval.
- Extended Maturity Date: November 16, 2015.
- Underlying Assets: Accounts receivables originated by AmerisourceBergen Drug Corporation (ABDC) from pharmaceutical sales and related services.
- Guarantor: AmerisourceBergen Corporation serves as the performance guarantor for ABDC's obligations.
Material Changes
The primary material change is the execution of a Third Amendment to the Amended and Restated Receivables Purchase Agreement. This amendment extends the maturity date of the existing $700 million securitization facility by three years, from its previous expiration to November 16, 2015. The filing text does not provide specific revenue, profit, cash flow, or margin figures for the period.
Outlook and Management Commentary
The amended facility is intended to provide additional liquidity and funding for the ongoing business needs of the Registrant and its subsidiaries. Bank of America, National Association, continues to serve as the administrator of the facility. The filing does not contain specific forward-looking guidance, risk factors, or commentary on unusual items beyond the description of the agreement's purpose.
Investor Verification Checklist
- Verify the terms of the Third Amendment to the Receivables Purchase Agreement (Exhibit 10.1).
- Confirm the utilization rate of the $700 million facility and any drawdowns under the $250 million seasonal expansion option.
- Review the company's overall liquidity position and debt maturity schedule in subsequent 10-Q or 10-K filings.
- Monitor the performance of ABDC's accounts receivables, which serve as the collateral for this facility.